CClinicalTrials.gg
Sign In
CompletedNCT01356056Updated Mar 12, 2013

Tele-diagnostics for Remote Parkinson's Monitoring

An observational study in Parkinson's Disease, sponsored by Great Lakes NeuroTechnologies Inc.. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2013-03-12.

Sponsored by Great Lakes NeuroTechnologies Inc. · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Sex
All
01

Study summary

The purpose of this research study is to design, implement, and clinically assess a portable, user worn system for monitoring Parkinson's disease (PD) motor symptoms. The current standard in evaluating symptoms is the Unified Parkinson's Disease Rating Scale (UPDRS), a subjective, qualitative ranking system. The main goal of this research is to develop a quantitative system, Kinesia HomeView, to assess tremor as well as different features of bradykinesia in a home based system which can capture those symptom changes over the course of a day and aid in evaluating treatment protocol efficacy.

02

Conditions studied

  • Parkinson's Disease

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 12 is below the median of 96 across 1,057 observational studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Great Lakes NeuroTechnologies Inc. is the lead sponsor of 19 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with Parkinson's disease

Inclusion criteria

  • Clinical diagnosis of Parkinson's disease

Exclusion criteria

Exclusion Criteria:

  • Inability to follow the required clinical instruction
  • Subjects with cognitive impairments that would prohibit them from properly using the Kinesia HomeView system
  • Subjects without the cognitive ability to respond to researchers and let them know when any parameters of the study may become uncomfortable
  • Subjects found on examination by our clinicians to have any physical limitations which would be counter productive to participation in this study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (actual)
Patient registry
No

Groups and cohorts

  • Kinesia HomeView Monitoring

    Uses Kinesia HomeView at home once per week

    Device: Kinesia HomeView

  • Control

    Assessed in the clinic every 4 weeks using traditional methods

Interventions

  • DeviceKinesia HomeView

    Quantifies motor symptom severity in the home

06

What researchers measure

Primary outcomes

  1. UPDRS

    Time frame: Every 4 weeks

  2. PDQ-39

    Time frame: Every 4 weeks

07

Study locations

1 site
  • University of Cincinnati
    Cincinnati, Ohio 45267, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01356056
Lead sponsor
Great Lakes NeuroTechnologies Inc.
Collaborators
University of Cincinnati
Responsible party
Sponsor
First posted
May 19, 2011
Start date
May 2011
Primary completion
Dec 2011
Last update
Mar 12, 2013
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Parkinson Disease→

Other studies from this sponsor

Great Lakes NeuroTechnologies Inc.

Start the discussion